‘Cell-based, innovative products for a better future’
Pluristem’s proprietary cell-based technology platform develops cutting-edge therapies and cultured food materials
IN COLLABORATION with the Tnuva Group, Pluristem will develop raw material for the cultured meat market. (photo credit: Wikimedia Commons)